Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06976268 · ClinicalTrials.gov registry record · Phase 2

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

A Phase 2 study of Parkinson Disease, sponsored by Biohaven Therapeutics.

Recruiting
Registry status
Phase 2
Development phase
550
Enrollment target
15
Study locations

NCT06976268 is a Phase 2 study of Parkinson Disease that is actively recruiting participants, run by Biohaven Therapeutics. The registered enrollment target is 550 participants, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (90% lower). The trial reports 15 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06976268, a Phase 2 study of Parkinson Disease, is actively recruiting participants, sponsored by Biohaven Therapeutics.

RECRUITING
Registry status
Phase 2
Development phase
550 participants
Enrollment target
15
Study locations

Study Summary

A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease.

Conditions Studied

Parkinson Disease

Interventions

  • DRUG Placebo
  • DRUG BHV-8000

Study Locations (15)

Florida

  • Site-038 - Atlantis
  • Site-017 - Boca Raton
  • Site-051 - Maitland

Connecticut

  • Site-031 - Farmington
  • Site-028 - New Haven

Alabama

  • Site-049 - Birmingham

California

  • Site-041 - Los Angeles

Illinois

  • Site-027 - Chicago

Massachusetts

  • Site-071 - Boston

Michigan

  • Site-015 - Farmington Hills

Missouri

  • Site-044 - Chesterfield

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2025-05-28
Est. Completion 2027-09
Phase Phase 2

Sponsor

Biohaven Therapeutics

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06976268

The ClinicalTrials.gov registry entry for NCT06976268 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (90% lower). The listed sponsor is Biohaven Therapeutics, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06976268 reports 15 study locations spanning 12 distinct geographic areas - top geographies include Florida, Connecticut, Alabama.

Frequently Asked Questions

What is clinical trial NCT06976268 about?

NCT06976268 is a clinical study titled "A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease". A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease.

What is the current status of trial NCT06976268?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 550 participants. The study started on 2025-05-28. Estimated completion is 2027-09.

What conditions does trial NCT06976268 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06976268?

The interventions under investigation include: Placebo (DRUG), BHV-8000 (DRUG).

Who is sponsoring clinical trial NCT06976268?

This trial is sponsored by Biohaven Therapeutics, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06976268 being conducted?

This trial has 15 study locations across Alabama, California, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.